Capricor Therapeutics Inc.

09/24/2024 | Press release | Distributed by Public on 09/24/2024 06:04

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy